Episode #20: The Future of Diagnostics: Technology driven personalised and preventative healthcare in Europe

On this episode of Life Sciences Connect podcast, we discuss these issues further with our panel of experts:

• Andy Flockhart, UK MedTech Leader
• Guido Baechler, CEO of Mainz Biomed

And of course, our host, Karen Taylor, Research Director, Centre for Health Solutions, Deloitte

Diagnostics play a pivotal role across the entire healthcare continuum from screening, detection and prognosis to patient stratification and condition monitoring.

While diagnostics have always been one of the foundations of healthcare, advances in science and technology mean they are now well positioned to play a key role in revolutionising healthcare. Driving the need for innovation are growing and ageing populations, the increasing prevalence of non-communicable diseases and chronic conditions, workforce shortages and an increasingly knowledgeable and empowered consumer base. However, innovative companies struggle to get their products to market due to a series of challenges, and as a result, diagnostics testing is taking much longer, causing backlogs in healthcare systems.

Listen to hear more on this topic.

Find out more

If you are interested in any of the topics discussed during this episode and want more information, please explore some useful links below:

• Stay up to date on industry issues by subscribing to our blog.

Life Sciences Connect

To see the full collections of episodes so far, please visit the Life Sciences Connect podcast library.